Zilico device increases cervical cancer detection by up to 24 per cent

The use of ZedScan in diagnostic screening has significantly increased the detection of cancer and potential cancer, according to the European Journal of Obstetrics & Gynecology and Reproductive Biology.

Part of Zilico, the British diagnostic technology for cervical cancer, ZedScan is an adjunct diagnostic device which uses Electrical Impedance Spectroscopy (EIS) technology to identify cell changes that cannot always be seen with standard colposcopy, providing immediate and accurate diagnosis of tissue which may be abnormal.

At colposcopy, clinicians look for cervical intra-epithelial neoplasia (CIN) or abnormal changes of the cells that line the cervix. These changes may be high or low grade.

With ZedScan, the biggest increase in cancer detection was found in women referred with low grade changes – often the most challenging to visualise – where the device had over a 50 per cent increase in high grade disease detection.

Already used by some NHS trusts and hospitals across Finland, the diagnostic tool will help provide better outcomes for women across the globe.

The cervical screening process screens for HPV infection. Those with HPV are then referred for colposcopy. In addition to traditional colposcopy methods, many NHS trusts have started using ZedScan for improved diagnostic information provided in real-time.

“It is fantastic news for patients in the UK and further afield,” says Sameer Kothari, Zilico CEO.  “Colposcopy has not materially changed for nearly 100 years and this data shows how having this advanced technology at the point of examination during colposcopy helps patients, clinicians and hospitals.

“Not only is this technology meaningful for the patient’s comfort and reassurance, it is quite simply detecting more problems accurately, and in greater detail, allowing people to access the treatment that they need more efficiently. This is important research here in the UK and Europe and has huge potential for the rest of the world and developing economies where cervical cancer often goes undetected.”

For more info, visit zilico.co.uk.